title: Effective therapeutic use of rituximab in refractory Wegener's granulomatosis.
authors.affiliation: Queen Elizabeth Hospital, Department of Nephrology, Birmingham, B15 2TT, UK.
authors.forename: Alistair J
authors.initials: AJ
authors.lastname: Ferraro
authors.forename: Clara J
authors.initials: CJ
authors.lastname: Day
authors.forename: Mark T
authors.initials: MT
authors.lastname: Drayson
authors.forename: Caroline O
authors.initials: CO
authors.lastname: Savage
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects; D014890:Granulomatosis with Polyangiitis / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018655:Lymphocyte Count; D016393:Lymphoma, B-Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab